The trademark application TMEkine was filed by Kanaph Therapeutics Inc., a corporation established under the laws of the Republic of Korea (the "Applicant"). The application was published for oppositions on August 25, 2020, and it was registered by office on December 2, 2020 without any oppositions.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 42 with following description of goods:
Medicine research
Research in the fields of medicine/surgery and specimen analysis
Biopsy for medical research
Blood testing for medical research
Medical and pharmacological research services
Scientific research for medical purposes in the field of cancerous diseases
Scientific research for medical purposes in the area of cancerous diseases
Consultancy and research in the field of bacteriology
Preparing and preserving tissue samples for use by others for medical purposes
Research on the subject of pharmaceuticals
Development of treatment preparations for removal of tumors
Technical research in the field of removal of tumors
Antibodies research
Technological research in the field of determining blood type genetic markers
Biotechnology research
Scientific research in the field of genetics
Biological research
Laboratory services relating to the production of monoclonal antibodies
Scientific research.
The mark was filed in class 44 with consultation and providing information in the fields of medicine/health and pharmacology.